CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy

According to the National Comprehensive Cancer Network clinical practice guidelines of cervical cancer, concurrent chemoradiotherapy or radiotherapy is suggested for patients who receive radical hysterectomy and have intermediate- and high-risk cervical cancer. However, adjuvant chemotherapy has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Awazu, Yuichiro, Fukuda, Takeshi, Noda, Takuya, Uchikura, Eijiro, Nanno, Shigenori, Imai, Kenji, Yamauchi, Makoto, Yasui, Tomoyo, Sumi, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398629/
https://www.ncbi.nlm.nih.gov/pubmed/37545614
http://dx.doi.org/10.3892/ol.2023.13939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398629/
https://www.ncbi.nlm.nih.gov/pubmed/37545614
http://dx.doi.org/10.3892/ol.2023.13939

Ejemplares similares